endometrial clear cell adenocarcinoma
Showing 1 - 23 of 23
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Active, not recruiting
- Endometrial Adenocarcinoma
- +9 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +232 more
Jan 12, 2023
Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,
Recruiting
- Cervical Adenocarcinoma
- +47 more
- Bevacizumab
- +3 more
-
Phoenix, Arizona
- +3 more
Dec 5, 2022
Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in United
Active, not recruiting
- Endometrial Clear Cell Adenocarcinoma
- +4 more
- Computed Tomography
- +5 more
-
Houston, Texas
- +6 more
Dec 5, 2022
Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in
Active, not recruiting
- Endometrial Adenosquamous Carcinoma
- +9 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +18 more
Oct 15, 2022
Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma Trial in
Recruiting
- Endometrial Clear Cell Adenocarcinoma
- +17 more
- Carboplatin
- +5 more
-
Birmingham, Alabama
- +376 more
Aug 24, 2022
Liquid Biopsies and Tumor Molecular Profiling in Predicting
Recruiting
- Endometrial Clear Cell Adenocarcinoma
- +5 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer Trial in Canada,
Active, not recruiting
- Endometrial Clear Cell Adenocarcinoma
- +5 more
- Cisplatin
- +3 more
-
Baltimore, Maryland
- +6 more
Apr 25, 2022
Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin
Active, not recruiting
- Breast Carcinoma
- +4 more
- Metformin Hydrochloride
- Doxycycline
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 28, 2022
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +4 more
- Akt Inhibitor MK2206
- Laboratory Biomarker Analysis
-
Boston, Massachusetts
- +6 more
Jan 13, 2022
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage IA Uterine Corpus Cancer AJCC v7 Trial in
Active, not recruiting
- Endometrial Clear Cell Adenocarcinoma
- +8 more
- Carboplatin
- +5 more
-
Birmingham, Alabama
- +669 more
Sep 28, 2021
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +5 more
- Laboratory Biomarker Analysis
- +2 more
-
Hartford, Connecticut
- +21 more
Oct 13, 2020
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +3 more
- Diagnostic Laboratory Biomarker Analysis
- Selumetinib
-
Los Angeles, California
- +71 more
Jul 19, 2019
Endometrial Cancer, Endometrial Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Oklahoma City (Mirvetuximab
Withdrawn
- Endometrial Cancer
- +3 more
- Mirvetuximab Soravtansine
- Bevacizumab
-
Oklahoma City, OklahomaStephenson Cancer Center
Jun 25, 2019
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States
Unknown status
- Endometrial Clear Cell Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +539 more
Mar 8, 2019
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Canada, Hong
Completed
- Endometrial Adenocarcinoma
- +11 more
- Bevacizumab
- +4 more
-
Berkeley, California
- +40 more
Feb 15, 2018
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +8 more
- Brivanib Alaninate
- Laboratory Biomarker Analysis
-
Aurora, Colorado
- +34 more
Nov 2, 2017
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma Trial in United States
Completed
- Endometrial Adenocarcinoma
- +8 more
-
Burbank, California
- +58 more
Sep 8, 2017
Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma Trial in United
Completed
- Endometrial Adenosquamous Carcinoma
- +10 more
- Cisplatin
- +4 more
-
Hartford, Connecticut
- +8 more
Aug 23, 2017
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in Philadelphia
Completed
- Endometrial Adenocarcinoma
- +5 more
- Doxorubicin Hydrochloride
- +4 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Apr 30, 2015
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia
Completed
- Endometrial Adenocarcinoma
- +4 more
- Doxorubicin Hydrochloride
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Dec 29, 2014
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer Trial in Philadelphia
Completed
- Endometrial Clear Cell Adenocarcinoma
- +3 more
- Paclitaxel
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Dec 29, 2014